β-Catenin-Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Gary Hammer, MD, PhD, and team share their latest updates in Adrenal cancer.
Gary Hammer, MD, PhD, and team share their latest updates in Adrenal cancer.
Lona Mody, MD, and other palliative care team members help dispel some common myths around their profession.
Ray Zuo, MD, and Jason Knight, MD, PhD, discover a class of functional autoantibodies in antiphospholipid syndrome patients that contributes to the disease's development.
Sofia Merajver, MD, PhD, and team use microfluidic devices to track what happens to cancer cells as they migrate and take root in the brain.
Ray Zuo, MD, and team suggest antiphospholipid antibodies may be present in seemingly healthy people, increasing their risk of a heart attack or stroke over time.
Anna Lok, MD, and team examine data from an NIH-funded study to determine if there's any racial disparity in hepatitis B treatment initiation in North America.
Robert Fontana, MD, and team examine measuring blood levels of a short-lived protein to help predict which patients would survive without the help of a transplant.
Megan R. Haymart, MD, and team assess the current state of thyroid cancer care through exploration of possible over diagnosis to new therapies and health equity concerns.
Robert Fontana, MD examines data around a 2011 FDA drug mandate.
Eugene Chen, MD, PhD, discusses the development of an amino acid compound successfully treating nonalcoholic fatty liver disease in non-human primates; brings hope for first human treatment.
Robert Fontana, MD, finds that measuring blood levels of a short-lived protein helps predict which patients would survive without the help of a transplant.
Rodica Pop-Busui, MD, PhD, discusses how the price cap will affect diabetes patients.
Allison Schulman, MD MPH, discusses several non-invasive therapies for treating obesity.
Robert Fontana, MD, examines data around a 2011 FDA drug mandate.
James, Baker, MD; Kelly O’Shea, MD; and Charles Schuler, MD, find that having both a vaccination and a previous infection helps provide immunity against some COVID-19 variants.
Eric Brandt, MD, MHS, and Monica Colvin, MD, MS, discuss the connection between cannabis or alcohol use on cardiovascular disease.
Michael Heung, MD, discusses the reliability of an AI prediction model that assesses patient risk for developing acute kidney injury.
Robert Dickson, MD, and teams research suggests volatile organic compounds in breath could mark distinction between COVID-19, variants and non-COVID illnesses.
Tadd Hiatt, MD explains why it’s not safe to put off screening, even during the pandemic.